news
11-14-2013, 03:35 PM
The drug has been approved by the Food and Drug Administration to treat relapses of a rare blood cancer called mantle cell lymphoma.http://rss.nytimes.com/c/34625/f/642562/s/33ae76fd/sc/3/mf.gif
http://res3.feedsportal.com/social/twitter.png (http://share.feedsportal.com/share/twitter/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F14%2 Fbusiness%2Fdrug-to-treat-blood-cancer-gains-fda-approval.html%3Fpartner%3Drss%26emc%3Drss&t=Imbruvica%2C+Drug+to+Treat+Blood+Cancer%2C+Gains +F.D.A.+Approval) http://res3.feedsportal.com/social/facebook.png (http://share.feedsportal.com/share/facebook/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F14%2 Fbusiness%2Fdrug-to-treat-blood-cancer-gains-fda-approval.html%3Fpartner%3Drss%26emc%3Drss&t=Imbruvica%2C+Drug+to+Treat+Blood+Cancer%2C+Gains +F.D.A.+Approval) http://res3.feedsportal.com/social/linkedin.png (http://share.feedsportal.com/share/linkedin/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F14%2 Fbusiness%2Fdrug-to-treat-blood-cancer-gains-fda-approval.html%3Fpartner%3Drss%26emc%3Drss&t=Imbruvica%2C+Drug+to+Treat+Blood+Cancer%2C+Gains +F.D.A.+Approval) http://res3.feedsportal.com/social/googleplus.png (http://share.feedsportal.com/share/gplus/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F14%2 Fbusiness%2Fdrug-to-treat-blood-cancer-gains-fda-approval.html%3Fpartner%3Drss%26emc%3Drss&t=Imbruvica%2C+Drug+to+Treat+Blood+Cancer%2C+Gains +F.D.A.+Approval) http://res3.feedsportal.com/social/email.png (http://share.feedsportal.com/share/email/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F14%2 Fbusiness%2Fdrug-to-treat-blood-cancer-gains-fda-approval.html%3Fpartner%3Drss%26emc%3Drss&t=Imbruvica%2C+Drug+to+Treat+Blood+Cancer%2C+Gains +F.D.A.+Approval)
More... (http://www.nytimes.com/2013/11/14/business/drug-to-treat-blood-cancer-gains-fda-approval.html?partner=rss&emc=rss)
http://res3.feedsportal.com/social/twitter.png (http://share.feedsportal.com/share/twitter/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F14%2 Fbusiness%2Fdrug-to-treat-blood-cancer-gains-fda-approval.html%3Fpartner%3Drss%26emc%3Drss&t=Imbruvica%2C+Drug+to+Treat+Blood+Cancer%2C+Gains +F.D.A.+Approval) http://res3.feedsportal.com/social/facebook.png (http://share.feedsportal.com/share/facebook/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F14%2 Fbusiness%2Fdrug-to-treat-blood-cancer-gains-fda-approval.html%3Fpartner%3Drss%26emc%3Drss&t=Imbruvica%2C+Drug+to+Treat+Blood+Cancer%2C+Gains +F.D.A.+Approval) http://res3.feedsportal.com/social/linkedin.png (http://share.feedsportal.com/share/linkedin/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F14%2 Fbusiness%2Fdrug-to-treat-blood-cancer-gains-fda-approval.html%3Fpartner%3Drss%26emc%3Drss&t=Imbruvica%2C+Drug+to+Treat+Blood+Cancer%2C+Gains +F.D.A.+Approval) http://res3.feedsportal.com/social/googleplus.png (http://share.feedsportal.com/share/gplus/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F14%2 Fbusiness%2Fdrug-to-treat-blood-cancer-gains-fda-approval.html%3Fpartner%3Drss%26emc%3Drss&t=Imbruvica%2C+Drug+to+Treat+Blood+Cancer%2C+Gains +F.D.A.+Approval) http://res3.feedsportal.com/social/email.png (http://share.feedsportal.com/share/email/?u=http%3A%2F%2Fwww.nytimes.com%2F2013%2F11%2F14%2 Fbusiness%2Fdrug-to-treat-blood-cancer-gains-fda-approval.html%3Fpartner%3Drss%26emc%3Drss&t=Imbruvica%2C+Drug+to+Treat+Blood+Cancer%2C+Gains +F.D.A.+Approval)
More... (http://www.nytimes.com/2013/11/14/business/drug-to-treat-blood-cancer-gains-fda-approval.html?partner=rss&emc=rss)